AzTrials
AzTrials

Anxiety DisordersIEH-RTCNCT06844058

Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression

A study testing Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in people with Anxiety Disorders and Depressive Disorder, run by Istanbul Nisantasi University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Anxiety Disorders, Depressive Disorder
What is being tested?
Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jan 2025to 15 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Muslim individuals aged 18-65 years.
  • Mild to moderate anxiety and/or depression symptoms (assessed via Beck
  • Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)).
  • No formal psychiatric diagnosis but experiencing psychological distress.
  • High religious belief levels, assessed via OK-Religious Attitude Scale.
  • Not currently receiving psychotherapy or psychotropic medication.
  • Ability to give informed consent and complete the study requirements.

Who cannot join

  • Severe psychiatric disorders (schizophrenia, bipolar disorder, severe MDD).
  • Current use of psychotropic medication or undergoing psychotherapy.
  • History of substance abuse or dependence.
  • Diagnosed dissociative disorders (contraindications for hypnosis).
  • Cognitive impairment affecting comprehension of intervention.
  • Severe medical conditions that may interfere with participation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • İstanbul Nişantaşı University

    Istanbul, 34277

    Metin Çınaroğlu, Phd, 05324732070, metincinaroglu@gmail.com

    Gözde Mert, Phd, +905359403399, gozde.mert@nisantasi.edu.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Efficacy of Islamic-Oriented Ericksonian Hypnotherapy vs. Standard Ericksonian Hypnotherapy in Reducing Anxiety and Depression: A Randomized Controlled Trial

This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. The study will enroll 90 participants with mild to moderate anxiety and depression, who will be randomly assigned to one of three groups: (1) IEH intervention, (2) SEH intervention, or (3) control group (no intervention). Participants in the intervention groups will receive 12 weekly hypnotherapy sessions, each lasting 60 minutes. The primary outcomes include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to post-intervention and at a 4-week follow-up.

The study will also assess whether religious belief levels moderate the effects of the intervention using the OK-Religious Attitude Scale. Data collection will be performed at Istanbul Nişantaşı University, and ethical approval has been obtained.

Read the detailed description

This randomized controlled trial evaluates the differential effects of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in alleviating symptoms of anxiety and depression among religious Muslim adults. The primary objective is to examine whether the integration of Islamic religious elements into Ericksonian hypnotherapy enhances clinical outcomes compared to its standard application.

The study follows a parallel-group design with three arms: IEH, SEH, and a no-intervention control. Ninety participants (30 per group) are randomized using stratified block randomization based on age and gender. All intervention sessions are manualized, delivered by trained clinical psychologists, and conducted weekly over 12 weeks (each lasting 60 minutes).

IEH sessions incorporate culturally and religiously adapted therapeutic elements, such as Quranic metaphors, Islamic imagery, and spiritual affirmations, in line with the Ericksonian framework. SEH sessions utilize traditional hypnotic techniques including metaphorical storytelling, guided imagery, and indirect suggestions, without religious content.

Primary outcome measures include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to Week 12 (post-intervention) and Week 16 (follow-up). Secondary analyses will investigate whether religiosity levels (measured via the OK-Religious Attitude Scale) moderate treatment effects. Blinded outcome assessors will ensure unbiased data collection.

This study addresses the need for culturally responsive mental health interventions within Muslim populations. Ethical approval was obtained from the İstanbul Nişantaşı University Ethics Committee (Approval No: 20250103-27). Results are expected to contribute to evidence-based development of spiritually integrated psychotherapeutic models for anxiety and depression.

Being tested
Islamic-Oriented Ericksonian Hypnotherapy (IEH), Standard Ericksonian Hypnotherapy (SEH)
Keywords
Hypnotherapy, Ericksonian Hypnosis, Islamic Psychology, Anxiety Reduction, Depression Treatment, Culturally Adapted Psychotherapy, Religious-Based Therapy
Medical subject headings
Anxiety Disorders, Depressive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Islamic-Oriented Ericksonian Hypnotherapy (IEH)Behavioural

    This intervention involves 12 weekly sessions (60 minutes each) of Ericksonian hypnotherapy integrated with Islamic religious elements. Sessions incorporate:

    Quranic metaphors and Islamic imagery Spiritual affirmations to enhance relaxation and emotional regulation Faith-based guided hypnosis adapted to cultural and religious beliefs Techniques such as indirect suggestions, therapeutic storytelling, and guided imagery The intervention is designed for Muslim participants with mild to moderate anxiety and depression.

  • Standard Ericksonian Hypnotherapy (SEH)Behavioural

    Participants receive 12 weekly sessions (60 minutes each) of standard Ericksonian hypnotherapy, which includes:

    Metaphorical storytelling and guided imagery Indirect hypnotic suggestions to promote psychological flexibility Relaxation techniques to reduce anxiety and depressive symptoms Unlike the Islamic-Oriented Hypnotherapy (IEH), this intervention does not integrate religious or faith-based elements.

Study groups in NCT06844058
Study groupRoleWhat they receive
Islamic-Oriented Ericksonian Hypnotherapy (IEH) GroupExperimentalParticipants receive 12 weekly sessions of Islamic-Oriented Ericksonian Hypnotherapy (IEH), which integrates faith-based imagery, Quranic metaphors, and religiously adapted hypnotic suggestions alongside standard Ericksonian techniques. Each session lasts 60 minutes.
Receives: Behavioral: Islamic-Oriented Ericksonian Hypnotherapy (IEH)
Standard Ericksonian Hypnotherapy (SEH) GroupActive comparatorParticipants receive 12 weekly sessions of Standard Ericksonian Hypnotherapy (SEH), using metaphorical storytelling, indirect suggestions, guided imagery, and hypnotic language patterns without religious integration. Each session lasts 60 minutes.
Receives: Behavioral: Standard Ericksonian Hypnotherapy (SEH)
Control Group (No Intervention)No interventionParticipants do not receive any intervention but will complete assessments at baseline, post-intervention (Week 12), and follow-up (Week 16).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Beck Depression Inventory-II (BDI-II)

    The study evaluates the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) vs. Standard Ericksonian Hypnotherapy (SEH) vs. No Intervention in reducing depressive symptoms. Depression severity will be assessed using the Beck Depression Inventory-II (BDI-II), comparing baseline, post-intervention (Week 12), and follow-up (Week 16) scores.

    Measured: Baseline, Week 12 (post-intervention), Week 16 (follow-up)

  2. Beck Anxiety Inventory (BAI)

    The study measures reductions in anxiety symptoms among participants receiving IEH, SEH, or no intervention. Anxiety severity will be assessed using the Beck Anxiety Inventory (BAI), comparing scores from baseline to post-intervention and follow-up.

    Measured: Baseline, Week 12, Week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start15 Jan 2025
  3. Primary completion25 Jun 2025 (estimated)
  4. Study completion15 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study follows a parallel-group randomized controlled design, where participants are assigned to one of three groups: Islamic-Oriented Ericksonian Hypnotherapy (IEH), Standard Ericksonian Hypnotherapy (SEH), or a control group with no intervention. Each participant remains in the same group throughout the study period.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06844058
Sponsor's protocol ID
IEH
Acronym
IEH-RTC
Status last verified
Mar 2025
First submitted
19 Feb 2025
Last updated
26 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified individual participant data (IPD) will be shared upon publication of the study results in a peer-reviewed journal. The shared dataset will include anonymized scores from outcome measures (e.g., BDI-II, BAI) and will exclude any personally identifiable information. Data will be available upon reasonable request for research purposes.

Questions about this trial

What is this clinical trial studying?

A study testing Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in people with Anxiety Disorders and Depressive Disorder, run by Istanbul Nisantasi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Metin Çınaroğlu, Phd (+905324732070, metin.cinaroglu@nisantasi.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Beck Depression Inventory-II (BDI-II) (time frame: Baseline, Week 12 (post-intervention), Week 16 (follow-up)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in